CBLL
CeriBell, Inc.
1W: +0.2%
1M: -8.8%
3M: -14.2%
YTD: -13.1%
1Y: -10.3%
$18.50
-0.53 (-2.79%)
After Hours: $18.09 (-0.41, -2.24%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$696.4M
52W Range10.01-24.33
Volume292,561
Avg Volume355,738
Beta1.11
Dividend—
Analyst Ratings
Company Info
CEOXingjuan Chao
Employees281
SectorHealthcare
IndustryMedical - Devices
IPO Date2024-10-11
Websiteceribell.com
360 North Pastoria Avenue
Sunnyvale, CA 94085
US
Sunnyvale, CA 94085
US
800 436 0826
About CeriBell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Latest News
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Target Price at $24.67
CeriBell outlines $111M–$115M 2026 revenue target as new neuromonitoring products launch
CeriBell, Inc. (CBLL) Q4 2025 Earnings Call Transcript
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
CeriBell GAAP EPS of -$0.36 beats by $0.05, revenue of $24.8M beats by $0.85M
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Foehr David | M-Exempt | 3,403 | $4.70 | 2026-03-03 |
| Foehr David | S-Sale | 1,157 | $17.80 | 2026-03-03 |
| Foehr David | M-Exempt | 1,157 | $4.70 | 2026-03-03 |
| Foehr David | M-Exempt | 3,403 | $4.70 | 2026-03-03 |
| Foehr David | M-Exempt | 1,157 | $4.70 | 2026-03-03 |